Trial intelligence / Profile preview

Intraspinal Gabapentin (MDT2004) for Chronic Intractable Pain

NCT00414466Phase 2Terminated

Sponsor
Medtronic
Start
Dec 2006
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gabapentin in Intractable Pain Syndrome (IPS), sponsored by Medtronic. Started Dec 2006; status: terminated.

02

Drugs

gabapentin
03

Conditions

Intractable Pain Syndrome (IPS)

Beyond the preview

Go deeper on NCT00414466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00414466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call